Unlisted share link — this page is not indexed. Content reflects a subscriber-generated snapshot; not investment advice. merkapitalresearch.com
Merkapital Research
Institutional Equity Research (Educational)
Equity Research Note

NKE — Nike's Turnaround Efforts Show Mixed Progress

NKE|March 31, 2026

This note was shared via an unlisted link from a subscriber Thesis Plan workflow (news narrative → Scenario Lab → risk framework → listed-options context). User-generated inputs may appear below. For information only — not a recommendation or personalized advice.

Executive Summary

  • Thesis: Nike's recent earnings report indicates some improvement in its wholesale business, but challenges remain in direct-to-consumer sales and the Chinese market.
  • Reference spot: $52.67 · Scenario-implied fair value: $63.80 · Upside anchor: $63.80 (~+21.2% vs spot)
  • Risk framework: Volatility-adjusted stop at $50.18 (~4.7% below spot); risk/reward 4.49 : 1 vs modeled upside anchor.
  • Derivatives: Listed options snapshot unavailable (No valid bull call spread for ~6m / ~12m expirations (illiquid chain or R:R filter)).

Overview metrics

Quantitative snapshot from the Merkapital dashboard (same fields as Stocks → Overview Metrics), frozen at Thesis Plan save time.

Confidence Score
66
P(Up) 1Y
62%
Exp. Return (median 1Y)
+9.5%
Volatility (model)
+31.2%
1Y range (10th–90th)
-26.1%+64.1%
U/D ratio
2.46
Momentum (3-1m)
-5.2%
Merkapital Trend™
% to analyst target
+42.4%
PEG
1.15
ROE (TTM)
+17.9%
Op. margin (TTM)
+8.1%
Profit margin
+5.4%
Analyst target
$74.97
Fwd P/E
20.8
EPS TTM
1.71
Confidence factor breakdown (0–100 each)
Earnings growth
0
Analyst consensus
1
Value (PEG)
1
Quality
-0
Momentum
-0
Market base
1

Shared link — Merkapital research note (educational)

Key developments & media context

Catalyst / news flow (seed narrative)

User- or feed-supplied narrative used as the seed for the thesis map and scenario work below.

Context from Ask AI thread: Draft an investment thesis in response to this innovation signal: main bull and bear cases, second-order effects, key catalysts, and what would invalidate the view. The article tone is neutral or mixed — still treat the story as a catalyst to stress-test. Innovation Radar category: Analyst Changes. Headline: Nike results tops estimates as turnaround shows uneven progress Indexed excerpt (from publisher feed): NIKE beat expectations for third-quarter earnings on Tuesday, as the sportswear giant's turnaround efforts showed some signs of progress, particularly in its wholesale business, even as weakness in China and margin pressure persisted. Under CEO Elliott Hill, Nike has pulled back promotions, stepped up product innovation and refocused on core franchises such as running as it tries to reset the business after years of excess inventory and uneven demand across North America and China. "The work is not finished, but the direction is clear, our teams are moving with focus and urgency," Hill said. The sportswear retailer's revenue was flat at US$11.28 billion in the quarter ended Feb 28, but came in above analysts' average estimate of a 0.3 per cent drop to US$11.24 billion, according to data compiled by LSEG. It earned 35 cents per share, beating estimates of 28 cents. But the turnaround remains uneven. In the reported quarter, wholesale revenue jumped 5 per cent to US$6.5 billion, helped by stable sales in North America. But its direct-to-customer sales fell 4 per cent, dragged by muted demand in Europe and China. Shares of the company were down 3 per cent after the bell. The stock has lost about 17 per cent of its value in the last 12 months. "For what it's worth, the US has been the area Nike has been performing best in our visibility and, as such, a dent to American consumer confidence would blunt Nike's recovery efforts," said Drake MacFarlane, analyst at M Science. China has remained a sore spot, with sales sliding 7 per cent in the reported quarter. In its second-largest market outside North America, the company has struggled with weaker product assortments, while slower innovation has led to share losses against fast-rising local competitors, including Anta and Li Ning. The company's gross profit margin contracted for a sixth straight quarter, falling 130 basis points to 40.2 per cent, mainly due to tariffs. REUTERS Source: The Business Times. Article URL: https://www.businesstimes.com.sg/companies-markets/consumer-healthcare/nike-results-tops-estimates-turnaround-shows-uneven-progress

Shared link — Merkapital research note (educational)

Revenue scenario

The following reflects consolidated revenue and segment mix assumptions recorded at the time this report was generated, benchmarked to the mapped segment disclosure and SEC-sourced consolidated revenue where applicable. Competitive positioning and filing references are provided for context only. These amounts represent hypothetical scenario inputs prepared in the research workflow and are not forecasts, targets, or projections of actual results.

Scenario consolidated revenue$46,309,000,000

Scenario basis: Forward analyst revenue estimate for the period ending May 31, 2027. Segment mix is benchmarked to the competitive map segment disclosure (FY 2025 (period end 2025-05-31)).

Change vs baseline+0.0%
Baseline (map)$46,309,000,000
SegmentMap %Thesis %
Footwear65.0%65.0%
Apparel30.0%30.0%
Equipment5.0%5.0%
Competitive position

leader

Consolidated revenue (SEC)

$46.31B

Segment period

FY 2025 (period end 2025-05-31)

Segments (from map)

Footwear · Apparel · Equipment

Shared link — Merkapital research note (educational)

Scenario Lab

Earnings and multiple assumptions from the Thesis Plan wizard (step 3), prior to the execution plan below.

Last close
$52.67
Consensus EPS (next FY, baseline)
$2.38
Scenario EPS
$2.73
Forward P/E (baseline)
20.8×
Scenario forward P/E
23.3×
Street-implied (baseline)
$49.54
Scenario implied fair value
$63.80
Analyst target
$74.97
Scenario vs spot
+21.2%

Frozen at Thesis Plan save; does not update with live quotes.

Shared link — Merkapital research note (educational)

Valuation & Scenario Overlay

MetricValue
Last / model spot$52.67
Consensus analyst target (where available)$74.97
Scenario Lab implied price$63.80
Thesis upside anchor (options / R:R)$63.80
ATR-style volatility proxy (14d scale)$1.65
Annualized vol (model)31.2%
Risk per share (spot − stop)$2.48
Reward per share (anchor − spot)$11.14

Shared link — Merkapital research note (educational)

Risk Management & Invalidation

Volatility-adjusted stop: consider closing or reducing if price ≤ $50.18 (entry − 1.5× ATR proxy using model volatility). Scenario upside anchor: $63.80. Educational workflow only — not advice.

Stop / downside anchor
$50.18
Risk : reward (per share)
4.49 : 1

Shared link — Merkapital research note (educational)

Listed Options — Expression of View

Structures are algorithmically selected from available chains (bull call spread; ~6m and ~12m anchors). Quotes may be delayed; liquidity and execution assumptions not modeled here.

No valid bull call spread for ~6m / ~12m expirations (illiquid chain or R:R filter)

Shared link — Merkapital research note (educational)

Investment Thesis Map

Nike's Turnaround Efforts Show Mixed Progress

Rotations & relative value

As Nike struggles, investors may rotate into local competitors like Anta, which could offer better growth prospects.

Weaker / avoid: NKERelative / beneficiaries: ANRAY

Constructive angles

Constructive

Invest in Nike as a turnaround play with potential for recovery in North America.

NKE

Nike has shown signs of progress in its wholesale business and has a strong brand presence in North America.

Mechanism: If consumer confidence remains stable in the U.S., Nike's revenue could improve, leading to a potential recovery in its stock price.

Constructive

Consider investing in local competitors like Anta and Li Ning.

ANTA, LNNGF

The ongoing weakness in Nike's performance in China may benefit local brands that are capturing market share.

Mechanism: As Nike struggles with product assortment and innovation in China, local competitors could see increased sales, leading to stock price appreciation.

Constructive

Invest in suppliers of materials and technology used by Nike.

VFC, DECK

As Nike focuses on product innovation, its suppliers may benefit from increased demand for high-quality materials.

Mechanism: Increased production and innovation at Nike may drive higher orders from suppliers, positively impacting their revenues.

Cautious / bearish angles

Cautious / short-bias

Be cautious on Nike due to ongoing margin pressure.

NKE

Nike's gross profit margin has contracted for six consecutive quarters, which could indicate ongoing financial strain.

Mechanism: Continued margin pressure from tariffs and competition may lead to reduced profitability, negatively impacting stock performance.

Cautious / short-bias

Short Nike's competitors that rely heavily on the Chinese market.

LULU, ADDYY

If Nike's struggles in China continue, it could create a negative ripple effect for other brands in the region.

Mechanism: Weakness in consumer demand in China may lead to lower sales for competitors, resulting in downward pressure on their stock prices.

Cautious / short-bias

Be cautious on retail-focused ETFs.

XRT

If consumer confidence declines, retail stocks, including Nike, may face significant headwinds.

Mechanism: A downturn in consumer spending could negatively impact the entire retail sector, leading to ETF underperformance.

Second-order effects

  • Increased competition in the sportswear market as local brands gain traction.
  • Potential shifts in consumer preferences towards sustainable and innovative products.
  • Impact on retail partners and wholesalers if Nike's turnaround fails to materialize.

Risks & invalidation

  • A significant improvement in Nike's direct-to-consumer sales could invalidate bearish views.
  • Unexpected positive economic indicators in China may boost Nike's performance.
  • Successful product innovation could lead to a resurgence in Nike's market share.

Suggested news monitors

Nike earnings report · Nike China market performance · Nike margin pressure · Anta Li Ning competition · Nike turnaround strategy

Important Disclosures

This document is generated by Merkapital's research tooling for informational and educational purposes only. It does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security or derivative. Scenario outputs depend on user inputs and model assumptions; actual results may differ materially.

Options involve substantial risk and are not suitable for all investors. Past performance does not guarantee future results.

Shared Merkapital research note — unlisted link

merkapitalresearch.com